Militia Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.66M Sell
1,540
-1,060
-41% -$1.01M 0.63% 46
2025
Q3
$1.98M Buy
2,600
+2,000
+333% +$1.49M 0.92% 25
2025
Q2
$468K Buy
+600
New +$466K 0.22% 112

Other funds holding LLY

Militia Capital Partners's LLY Position: Q4 2025 in Review

Militia Capital Partners reduced its Eli Lilly (LLY) stake by 41% in Q4 2025, selling an estimated $1.01M and leaving 1,540 shares worth $1.66M. The position accounts for 0.63% of the portfolio, ranked #46.

Militia Capital Partners first reported a position in LLY in Q2 2025 and has held it in 3 quarters since. The position peaked at $1.98M in Q3 2025. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Militia Capital Partners held 1,540 shares of Eli Lilly worth $1.66M as of Q4 2025.
  • Militia Capital Partners sold 1,060 Eli Lilly shares in Q4 2025, an estimated $1.01M.
  • Eli Lilly made up 0.63% of Militia Capital Partners's portfolio in Q4 2025, its #46 holding.
  • Militia Capital Partners first reported a position in Eli Lilly in Q2 2025 and has held it in 3 quarters since.
  • Militia Capital Partners's Eli Lilly position peaked at $1.98M in Q3 2025.
  • 4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Militia Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.